“`html
Shares of Cogent Biosciences Inc (COGT) recently surged to $32.46 each, exceeding the average 12-month analyst target price of $22.92. This shift signals possible reactions from analysts, who may choose to either downgrade the stock on valuation grounds or adjust their price targets higher.
Currently, there are 13 analysts covering COGT, with price targets ranging from $11.00 to $44.00 and a standard deviation of $9.078. The recent analyst ratings show 10 strong buy, 5 hold, and no sell recommendations, resulting in an average rating of 1.67.
“`
